Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2021 Jul 16;30(10):1826–1833. doi: 10.1158/1055-9965.EPI-21-0234

Table 4.

Cancer risk in diethylstilbestrol (DES) exposed compared with unexposed men

DES Status
Exposed Cases
PYc = 47,322
Unexposed Cases
PYc = 45,256
HRa (95% CIb)
All Sites 187 206 0.94 (0.77, 1.15)
Digestive System (colon, rectum) 37 32 1.16 (0.72, 1.88)
 Colon and rectum 18 17 1.18 (0.60, 2.31)
Liver 6 3 1.73 (0.43, 7.00)
Lung and bronchus 19 21 1.02 (0.55, 1.92)
Prostate 65 72 0.95 (0.68, 1.33)
Testis 6 3 1.74 (0.43, 7.07)
Urinary system (bladder, kidney) 11 23 0.48 (0.23, 1.00)
 Bladder 4 13 0.29 (0.09, 0.90)
 Kidney and renal pelvis 7 10 0.74 (0.28, 1.96)
Thyroid 7 7 1.09 (0.38, 3.17)
Lymphoma 8 11 0.91 (0.35, 2.37)
Leukemia 10 10 0.94 (0.39, 2.29)
a

HR Hazard ratio, with age as the underlying time variable, adjusted for birth year and cohort.

b

CI Confidence interval

c

PY Person-years